XML 20 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1Close
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Mar. 29, 2024
Mar. 31, 2023
Mar. 29, 2024
Mar. 31, 2023
Income Statement [Abstract]        
Revenue, net $ 3,457 $ 2,803 $ 9,239 $ 9,646
Cost of revenue 2,456 2,517 7,647 7,851
Gross profit 1,001 286 1,592 1,795 Close
Operating expenses:        
Research and development 494 476 1,369 1,551
Selling, general and administrative 203 242 608 739
Employee termination, asset impairment, and other 8 40 89 140
Business separation costs 23 0 59 0
Total operating expenses 728 758 2,125 2,430 Close
Operating income (loss) 273 (472) (533) (635) Close
Interest and other expense:        
Interest income 10 10 30 15
Interest expense (108) (80) (314) (223)
Other income, net 3 14 54 27
Total interest and other expense, net (95) (56) (230) (181) Close
Income (loss) before taxes 178 (528) (763) (816) Close
Income tax expense 43 43 74 159 Close
Net income (loss) 135 (571) (837) (975) Close
Less: cumulative dividends allocated to preferred shareholders 15 9 44 9
Less: income attributable to preferred shareholders 7 0 0 0
Net income (loss) attributable to common shareholders $ 113 $ (580) $ (881) $ (984)
Net income (loss) per common share:        
Basic (in dollars per share) $ 0.35 $ (1.82) $ (2.72) $ (3.09)
Diluted (in dollars per share) $ 0.34 $ (1.82) $ (2.72) $ (3.09)
Weighted average shares outstanding:        
Basic (in shares) 326 319 324 318
Diluted (in shares) 335 319 324 318